(NASDAQ: AIRS) Airsculpt Technologies's forecast annual revenue growth rate of 2.62% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.2%.
Airsculpt Technologies's revenue in 2026 is $150,724,000.On average, 5 Wall Street analysts forecast AIRS's revenue for 2026 to be $11,107,708,851, with the lowest AIRS revenue forecast at $10,572,762,400, and the highest AIRS revenue forecast at $11,536,675,344. On average, 5 Wall Street analysts forecast AIRS's revenue for 2027 to be $11,401,857,303, with the lowest AIRS revenue forecast at $10,861,864,188, and the highest AIRS revenue forecast at $11,824,335,228.
In 2028, AIRS is forecast to generate $11,822,893,324 in revenue, with the lowest revenue forecast at $11,311,738,292 and the highest revenue forecast at $12,220,137,926.